Your browser doesn't support javascript.
loading
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Rasche, Ludwig; Heiserich, Lisa; Behrens, Janina Ruth; Lenz, Klaus; Pfuhl, Catherina; Wakonig, Katharina; Gieß, René Markus; Freitag, Erik; Eberle, Caroline; Wuerfel, Jens; Dörr, Jan; Bauer, Peter; Bellmann-Strobl, Judith; Paul, Friedemann; Roggenbuck, Dirk; Ruprecht, Klemens.
Afiliação
  • Rasche L; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Heiserich L; Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Behrens JR; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Lenz K; Medipan GmbH, Berlin-Dahlewitz, Germany.
  • Pfuhl C; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Wakonig K; Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Gieß RM; Department of Medical Biometrics and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Freitag E; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Eberle C; Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Wuerfel J; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Dörr J; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Bauer P; Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Bellmann-Strobl J; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Paul F; Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Roggenbuck D; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Ruprecht K; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
PLoS One ; 11(1): e0147968, 2016.
Article em En | MEDLINE | ID: mdl-26820970
ABSTRACT

BACKGROUND:

In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. γ-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS).

OBJECTIVE:

To evaluate the significance of γ-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated γ-H2AX and 53BP1 foci detection.

METHODS:

Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with γ-H2AX and 53BP1 specific antibodies. Nuclear γ-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of γ-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. γ-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls.

RESULTS:

The median (range) number of γ-H2AX (0.04 [0-0.5]) and 53BP1 (0.005 [0-0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, γ-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. γ-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although γ-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, γ-H2AX values of both groups overlapped and γ-H2AX did not correlate with the number or volume of CEL.

CONCLUSION:

γ-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Histonas / Linfócitos / Peptídeos e Proteínas de Sinalização Intracelular / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Histonas / Linfócitos / Peptídeos e Proteínas de Sinalização Intracelular / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha